We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+0.79%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.02B
AUM Growth
+$4.67M
Cap. Flow
+$2.09M
Cap. Flow %
0.21%
Top 10 Hldgs %
30.27%
Holding
183
New
2
Increased
49
Reduced
56
Closed
6

Top Buys

Rank Stock Value
1
BLKB icon
Blackbaud
BLKB
+$880K
2
WLY icon
John Wiley & Sons Class A
WLY
+$642K
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$597K
4
USB icon
US Bancorp
USB
+$563K
5
CVX icon
Chevron
CVX
+$444K

Top Sells

Rank Stock Value
1
DOX icon
Amdocs
DOX
+$566K
2
SYK icon
Stryker
SYK
+$501K
3
MSFT icon
Microsoft
MSFT
+$415K
4
ARRY
Array Biopharma Inc
ARRY
+$369K
5
GS icon
Goldman Sachs
GS
+$321K

Sector Composition

Rank Sector Weight
1 Technology 25.57%
2 Healthcare 17.23%
3 Financials 11.97%
4 Consumer Staples 10.84%
5 Industrials 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HSY icon
151
Hershey
HSY
$37.3B
$289K 0.03%
1,862
– –
VO icon
152
Vanguard Mid-Cap ETF
VO
$106B
$287K 0.03%
6,860
– –
CTVA icon
153
Corteva
CTVA
$60.5B
$284K 0.03%
10,146
-728
-7% -$21K
EOG icon
154
EOG Resources
EOG
$77.7B
$264K 0.03%
3,555
– –
VB icon
155
Vanguard Small-Cap ETF
VB
$78.9B
$258K 0.03%
1,676
– –
GPC icon
156
Genuine Parts
GPC
$17.9B
$257K 0.03%
2,577
– –
YUM icon
157
Yum! Brands
YUM
$41.9B
$256K 0.03%
2,259
– –
CHX
158
DELISTED
ChampionX
CHX
$249K 0.02%
9,213
-1,767
-16% -$51.6K
DE icon
159
Deere & Co
DE
$165B
$243K 0.02%
1,439
– –
AME icon
160
Ametek
AME
$53.9B
$239K 0.02%
2,598
-26
-1% -$2.29K
SPY icon
161
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$237K 0.02%
800
– –
CACC icon
162
Credit Acceptance
CACC
$5.82B
$236K 0.02%
512
– –
ORLY icon
163
O'Reilly Automotive
ORLY
$75.1B
$235K 0.02%
8,850
– –
IWF icon
164
iShares Russell 1000 Growth ETF
IWF
$117B
$233K 0.02%
+5,832
New +$234K
NKE icon
165
Nike
NKE
$64.1B
$231K 0.02%
2,455
– –
BF.A icon
166
Brown-Forman Class A
BF.A
$13.7B
$228K 0.02%
3,814
– –
K
167
DELISTED
Kellanova
K
$227K 0.02%
3,764
-250
-6% -$14.3K
BIIB icon
168
Biogen
BIIB
$30.9B
$224K 0.02%
961
– –
NTRS icon
169
Northern Trust
NTRS
$21.8B
$223K 0.02%
2,387
– –
DVY icon
170
iShares Select Dividend ETF
DVY
$23.8B
$219K 0.02%
2,153
– –
VWO icon
171
Vanguard FTSE Emerging Markets ETF
VWO
$117B
$218K 0.02%
5,415
– –
IOSP icon
172
Innospec
IOSP
$2.09B
$214K 0.02%
2,400
– –
DFS
173
DELISTED
Discover Financial Services
DFS
$213K 0.02%
2,622
– –
BAC icon
174
Bank of America
BAC
$429B
$204K 0.02%
+6,982
New +$201K
EME icon
175
Emcor
EME
$29.9B
$202K 0.02%
2,350
– –
4 5 6
7
8

Similar funds

HHAM
HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $1.77B AUM 31.28% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
BCMIO
Beacon Capital Management Inc (Ohio) Dayton, Ohio $1.78B AUM 14.7% 1-Year Est. Return
UF
Univest Financial Souderton, Pennsylvania $1.78B AUM 22.52% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return

Grandfield & Dodd's Q3 2019 Portfolio in Review

As of Q3 2019, Grandfield & Dodd held 183 positions worth $1.02B, up 0.46% from $1.01B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 4.4%. Grandfield & Dodd opened 2 new positions and exited 6, leaving the 183-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Grandfield & Dodd's largest Q3 2019 buy was iShares Russell 1000 Growth ETF: 5,832 shares worth $233K.
  • Grandfield & Dodd added most to Blackbaud in Q3 2019, an estimated $880K increase.
  • Grandfield & Dodd's biggest Q3 2019 reduction was Amdocs, cutting an estimated $566K.
  • Grandfield & Dodd fully exited Array Biopharma Inc in Q3 2019, selling an estimated $369K.
  • Grandfield & Dodd's ten largest holdings make up 30% of its $1.02B portfolio in Q3 2019.
  • Grandfield & Dodd opened 2 new positions and closed 6 in Q3 2019.
  • Grandfield & Dodd's portfolio value rose 0.46% quarter-over-quarter to $1.02B.

Based on Grandfield & Dodd's 13F filing for Q3 2019, filed 30 Oct 2019.